BG Medicine

BG Medicine this week reported second quarter revenues of $1 million, up 62 percent from $622,000 in the second quarter of 2012.

NEW YORK (GenomeWeb News) – BG Medicine today reported second quarter revenues of $1 million, up 62 percent from $622,000 in the second quarter of 2012.

Joseph Kirkland was named the recipient of the first annual Uwe D. Neue Award in Separation Science this week at the 39th International Symposium on High-Performance-Liquid-Phase Separations and Related Techniques.

BG Medicine said this week that the 2013 American College of Cardiology Foundation and the American Heart Association Guideline for the Management of Heart Failure has for the first time recognized the role of galectin-3 testing.

NEW YORK (GenomeWeb News) – BG Medicine said late on Friday it has been notified by Nasdaq for the second time in less than six months that it does not fulfill a requirement for continued listing on the exchange.

BG Medicine this week reported first quarter revenues of $888,000, up 85 percent from $480,000 in the first quarter of 2012.

BG Medicine has tapped Paul Sohmer to be president, CEO, and a member of its board of directors, effective immediately, the company said this week. He replaces Eric Bouvier, who will remain with the company as a consultant.

NEW YORK (GenomeWeb News) – BG Medicine today reported first quarter revenues of $888,000, up 85 percent from $480,000 in the first quarter of 2012.
The company also announced that it had appointed Paul Sohmer as president and CEO, replacing Eric Bouvier.

With positive data from two validation studies in hand, diagnostics firm Pronota is prepping its acute heart failure protein biomarker CD146 for a 2014 launch.

Abbott this week received an EU CE mark for its automated version of BG Medicine's Galectin-3 protein biomarker assay.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.